Annual report pursuant to Section 13 and 15(d)

Schedule II - Valuation and Qualifying Accounts

v3.20.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2019
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts Disclosure

INTERPACE BIOSCIENCES, INC.

VALUATION AND QUALIFYING ACCOUNTS

YEARS ENDED DECEMBER 31, 2019 AND 2018

($ in thousands)

 

          Additions              
    Balance at     (Reductions)     (1)     Balance at  
    Beginning     Charged to     Deductions     end  
Description   of Period     Operations     Other     of Period  
2018 (As Restated)                                
Allowance for doubtful notes   $ 869       -       -     $ 869  
Tax valuation allowance   $ 46,308       -       1,587     $ 47,895  
                                 
2019 (As Restated)                                
Allowance for doubtful accounts   $ -       -       25     $ 25  
Allowance for doubtful notes   $ 869       -       -     $ 869  
Tax valuation allowance   $ 47,895       -       5,996     $ 53,891  

 

(1) Includes payments and actual write offs, as well as changes in estimates in the reserves.